Similar articles

• [Results of the ECHODIAH clinical trial on hip arthrosis].

  Vignon E. Vignon E. Presse Med. 2002 Jan 12;31(1 Pt 2):7-9. Presse Med. 2002. PMID: 11826591 Clinical Trial. French.
• [Evaluation methods of osteoarthritis: apropos of the ECHODIAH study].

  Dougados M, Nguyen M, Berdah L, Lequesne M, Mazières B, Vignon E. Dougados M, et al. Rev Prat. 1996 Mar 15;46(6 Spec No):S53-S56. Rev Prat. 1996. PMID: 8731733 Review. French. No abstract available.
• Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip.

  Dougados M, Nguyen M, Berdah L, Maziéres B, Vignon E, Lequesne M; ECHODIAH Investigators Study Group. Dougados M, et al. Arthritis Rheum. 2001 Nov;44(11):2539-47. doi: 10.1002/1529-0131(200111)44:11<2539::aid-art434>3.0.co;2-t. Arthritis Rheum. 2001. PMID: 11710710 Clinical Trial.
• Diacerein has a structure/disease-modifying effect on hip osteoarthritis.

  Provvedini DM. Provvedini DM. Clin Exp Rheumatol. 2004 Nov-Dec;22(6):788. Clin Exp Rheumatol. 2004. PMID: 15638061 No abstract available.
• [Efficacy of diacerein on the symptoms and radiographic progression of osteoarthritis].

  Provvedini D, Cohen P. Provvedini D, et al. Presse Med. 2002 Dec 7;31(39 Pt 2):4S13-5. Presse Med. 2002. PMID: 12518072 Review. French.